↓ Skip to main content

Hematologic Tumor Cell Resistance to the BCL-2 Inhibitor Venetoclax: A Product of Its Microenvironment?

Overview of attention for article published in Frontiers in oncology, October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hematologic Tumor Cell Resistance to the BCL-2 Inhibitor Venetoclax: A Product of Its Microenvironment?
Published in
Frontiers in oncology, October 2018
DOI 10.3389/fonc.2018.00458
Pubmed ID
Authors

Joel D. Leverson, Dan Cojocari

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 24%
Student > Ph. D. Student 13 19%
Student > Bachelor 8 11%
Student > Master 6 9%
Student > Doctoral Student 4 6%
Other 9 13%
Unknown 13 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 29 41%
Medicine and Dentistry 9 13%
Pharmacology, Toxicology and Pharmaceutical Science 6 9%
Immunology and Microbiology 4 6%
Agricultural and Biological Sciences 3 4%
Other 3 4%
Unknown 16 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2022.
All research outputs
#8,372,109
of 25,655,374 outputs
Outputs from Frontiers in oncology
#3,144
of 22,758 outputs
Outputs of similar age
#140,105
of 362,527 outputs
Outputs of similar age from Frontiers in oncology
#49
of 224 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,527 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 224 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.